Commonwealth Equity Services
BXRX

Commonwealth Equity Services’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History

Commonwealth Equity Services’s Portfolio BXRX Stock Details BXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15
Closed -$11K – 3774
2021
Q3 		$11K Sell
15
-1
-6% -$870 ﹤0.01% 3563
2021
Q2 		$17K Hold
16
– – ﹤0.01% 3505
2021
Q1 		$29K Hold
16
– – ﹤0.01% 3364
2020
Q4 		$23K Sell
16
-127
-89% -$260K ﹤0.01% 3171
2020
Q3 		$552K Buy
143
+26
+22% +$118K ﹤0.01% 1892
2020
Q2 		$677K Buy
+117
New +$561K ﹤0.01% 1672

Other funds holding BXRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AWA
Amplius Wealth Advisors Blue Bell, Pennsylvania $1.36B AUM 18.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Commonwealth Equity Services's BXRX Position: Q4 2021 in Review

Commonwealth Equity Services sold out of Baudax Bio, Inc. Common Stock (BXRX) in Q4 2021, closing a stake of 15 shares — an estimated $11K sold.

Commonwealth Equity Services first reported a position in BXRX in Q2 2020 and held it in 6 quarters. The position peaked at $677K in Q2 2020. 28 funds tracked by Wall St. Rank hold BXRX as of Q4 2021.

  • Commonwealth Equity Services reported no remaining Baudax Bio, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Commonwealth Equity Services sold 15 Baudax Bio, Inc. Common Stock shares in Q4 2021, an estimated $11K.
  • Commonwealth Equity Services first reported a position in Baudax Bio, Inc. Common Stock in Q2 2020 and held it in 6 quarters.
  • Commonwealth Equity Services's Baudax Bio, Inc. Common Stock position peaked at $677K in Q2 2020.
  • 28 funds tracked by Wall St. Rank held Baudax Bio, Inc. Common Stock as of Q4 2021.

Based on Commonwealth Equity Services's 13F filing for Q4 2021, filed 31 Jan 2022.